Table 2. Clinical characteristics and corresponding hydrocortisone dose of CAH female Patients with PCOS.

BMI - body mass index, CAH - congenital adrenal hyperplasia, PCOS - polycystic ovary syndrome

#	Age of detection	BMI	BMI Z-score	Tanner stage	Bone age advancement (years)	Hydrocortisone dose in mg/m2/day
1	20	27	1.18	V	3.0	17.9
2	20	50	2.39	V	3.0	15.5
3	18.6	22	0.03	V	2.2	10
4	17.6	19	0.90	V	2.3	10.7
5	17.5	29	1.32	V	2.1	18.29
6	17.1	44	2.34	V	2.6	14.15
7	16.1	25	1.09	V	2.0	15.5
8	16.1	24	0.51	V	3.0	20
9	15.1	33	1.79	V	2.1	14
10	14.2	24	1.20	IV	2.0	18.5
11	13.6	37	2.06	IV	2.0	15.6
12	12.5	25	1.24	IV	2.1	20